AU6421796A - Nucleic acid sequences and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use - Google Patents

Nucleic acid sequences and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use

Info

Publication number
AU6421796A
AU6421796A AU64217/96A AU6421796A AU6421796A AU 6421796 A AU6421796 A AU 6421796A AU 64217/96 A AU64217/96 A AU 64217/96A AU 6421796 A AU6421796 A AU 6421796A AU 6421796 A AU6421796 A AU 6421796A
Authority
AU
Australia
Prior art keywords
plasmids
nucleic acid
acid sequences
resistance mechanism
bacteria containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU64217/96A
Other versions
AU722216B2 (en
Inventor
Marlene Daloyau
Fabien Prevots
Sandrine Tolou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Degussa Health and Nutrition Holding France SAS
Original Assignee
Systems Bio Industries
Systems Bio Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9509980A external-priority patent/FR2738015B1/en
Application filed by Systems Bio Industries, Systems Bio Industries Inc filed Critical Systems Bio Industries
Publication of AU6421796A publication Critical patent/AU6421796A/en
Assigned to SKW BIOSYSTEMS reassignment SKW BIOSYSTEMS Amend patent request/document other than specification (104) Assignors: SYSTEMS BIO INDUSTRIES
Application granted granted Critical
Publication of AU722216B2 publication Critical patent/AU722216B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU64217/96A 1995-08-22 1996-08-22 Nucleic acid sequences and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use Ceased AU722216B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509980A FR2738015B1 (en) 1995-08-22 1995-08-22 DNA SEQUENCES AND PLASMIDS COMPRISING AT LEAST ONE PHASE RESISTANCE MECHANISM, BACTERIA CONTAINING THEM AND THEIR USE
FR9509980 1995-08-22

Publications (2)

Publication Number Publication Date
AU6421796A true AU6421796A (en) 1997-02-27
AU722216B2 AU722216B2 (en) 2000-07-27

Family

ID=9482030

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64217/96A Ceased AU722216B2 (en) 1995-08-22 1996-08-22 Nucleic acid sequences and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use

Country Status (1)

Country Link
AU (1) AU722216B2 (en)

Also Published As

Publication number Publication date
AU722216B2 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
EP0710667B8 (en) Modified oligonucleotides, their preparation and their use
EP0938337A4 (en) Chimeric kanamycin resistance gene
AU6625296A (en) Dna constructs
AU1249295A (en) Chemically regulatable and anti-pathogenic dna sequences and uses thereof
AU5793798A (en) Streptococcus pneumoniae dna sequences
AU1235392A (en) Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
AU1389597A (en) Novel dna glycosylases and their use
AU2317095A (en) Dna sequences
AU2417499A (en) High resistance polypropylene tube
AU6244296A (en) Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof
AU6057296A (en) DNA sequencing and DNA terminators
AU3979395A (en) DNA sequences and their use
ZA961082B (en) DNA sequence.
IL136826A0 (en) Essential bacterial genes and their use
AU3546595A (en) Dna sequence encoding squalene synthetase
AU660144B2 (en) DNA molecule and plasmid comprising at least one phage resistant mechanism, bacteria containing same and uses thereof
AU1981295A (en) Novel protein-kinase, nucleic acid sequences encoding the same and methods related thereto
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
AU6210696A (en) Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use
WO1998044134A3 (en) Bacterial plasmids
AU3849195A (en) Dna transfer method
AU6421796A (en) Nucleic acid sequences and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use
AU697722B2 (en) Novel topoisomerase IV, corresponding nucleotide sequences and uses thereof
AU1255899A (en) Dna encoding phage resistance protein
AU8423691A (en) Dna sequences involved in neuronal degeneration, multicellular organisms containing same and uses thereof

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired